Literature DB >> 25931407

Uncovering the mechanisms for statin-mediated dysglycaemia: role of Rac1?

Philip J Millar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25931407      PMCID： PMC4422575          DOI： 10.1113/JP270260

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  11 in total

Review 1.  Pleiotropic effects of statins.

Authors:  James K Liao; Ulrich Laufs
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 2.  Statins and the autonomic nervous system.

Authors:  Philip J Millar; John S Floras
Journal:  Clin Sci (Lond)       Date:  2014-03       Impact factor: 6.124

Review 3.  Rac1--a novel regulator of contraction-stimulated glucose uptake in skeletal muscle.

Authors:  Lykke Sylow; Lisbeth L V Møller; Maximilian Kleinert; Erik A Richter; Thomas E Jensen
Journal:  Exp Physiol       Date:  2014-09-18       Impact factor: 2.969

4.  Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.

Authors:  Charalambos Antoniades; Constantinos Bakogiannis; Dimitris Tousoulis; Svetlana Reilly; Mei-Hua Zhang; Andreas Paschalis; Alexios S Antonopoulos; Michael Demosthenous; Antigoni Miliou; Costas Psarros; Kyriakoula Marinou; Nikolaos Sfyras; George Economopoulos; Barbara Casadei; Keith M Channon; Christodoulos Stefanadis
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

5.  Stretch-stimulated glucose transport in skeletal muscle is regulated by Rac1.

Authors:  Lykke Sylow; Lisbeth L V Møller; Maximilian Kleinert; Erik A Richter; Thomas E Jensen
Journal:  J Physiol       Date:  2015-01-15       Impact factor: 5.182

6.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

7.  Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Authors:  Giuseppe Derosa; Arrigo F G Cicero; Angela D'Angelo; Elena Fogari; Sibilla Salvadeo; Alessia Gravina; Ilaria Ferrari; Raffaella Fassi; Roberto Fogari
Journal:  Clin Ther       Date:  2007-04       Impact factor: 3.393

8.  Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.

Authors:  Mamunur Rashid; Shunsuke Tawara; Yoshihiro Fukumoto; Minoru Seto; Kazuo Yano; Hiroaki Shimokawa
Journal:  Circ J       Date:  2008-12-08       Impact factor: 2.993

9.  Effect of statins on skeletal muscle function.

Authors:  Beth A Parker; Jeffrey A Capizzi; Adam S Grimaldi; Priscilla M Clarkson; Stephanie M Cole; Justin Keadle; Stuart Chipkin; Linda S Pescatello; Kathleen Simpson; C Michael White; Paul D Thompson
Journal:  Circulation       Date:  2012-11-26       Impact factor: 29.690

10.  Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle.

Authors:  Lykke Sylow; Thomas E Jensen; Maximilian Kleinert; Kurt Højlund; Bente Kiens; Jørgen Wojtaszewski; Clara Prats; Peter Schjerling; Erik A Richter
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.